STING1 and ovarian cancer: With respect to CTL recruitment, USP35 silencing counteracts stimulator of interferon genes (STING) deubiquitination, which facilitates STING-mediated upregulation of type I interferons and CD8+ T-cell infiltration in ovarian cancer [100].